Molecular differentiation between osteophytic and articular cartilage--clues for a transient and permanent chondrocyte phenotype

Osteoarthritis Cartilage. 2012 Feb;20(2):162-71. doi: 10.1016/j.joca.2011.12.004. Epub 2011 Dec 13.

Abstract

Objective: To identify the molecular differences between the transient and permanent chondrocyte phenotype in osteophytic and articular cartilage.

Methods: Total RNA was isolated from the cartilaginous layer of osteophytes and from intact articular cartilage from knee joints of 15 adult human donors and subjected to cDNA microarray analysis. The differential expression of relevant genes between these two cartilaginous tissues was additionally validated by quantitative reverse transcriptase polymerase chain reaction (RT-PCR) and by immunohistochemistry.

Results: Among 47,000 screened transcripts, 600 transcripts were differentially expressed between osteophytic and articular chondrocytes. Osteophytic chondrocytes were characterized by increased expression of genes involved in the endochondral ossification process [bone gamma-carboxyglutamate protein/osteocalcin (BGLAP), bone morphogenetic protein-8B (BMP8B), collagen type I, alpha 2 (COL1A2), sclerostin (SOST), growth arrest and DNA damage-induced gene 45ß (GADD45ß), runt-related transcription factor 2 (RUNX2)], and genes encoding tissue remodeling enzymes [matrix metallopeptidase (MMP)9, 13, hyaluronan synthase 1 (HAS1)]. Articular chondrocytes expressed increased transcript levels of antagonists and inhibitors of the BMP- and Wnt-signaling pathways [Gremlin-1 (GREM1), frizzled-related protein (FRZB), WNT1 inducible signaling pathway protein-3 (WISP3)], as well as factors that inhibit terminal chondrocyte differentiation and endochondral bone formation [parathyroid hormone-like hormone (PTHLH), sex-determining region Y-box 9 (SOX9), stanniocalcin-2 (STC2), S100 calcium binding protein A1 (S100A1), S100 calcium binding protein B (S100B)]. Immunohistochemistry of tissue sections for GREM1 and BGLAP, the two most prominent differentially expressed genes, confirmed selective detection of GREM1 in articular chondrocytes and that of BGLAP in osteophytic chondrocytes and bone.

Conclusions: Osteophytic and articular chondrocytes significantly differ in their gene expression pattern. In articular cartilage, a prominent expression of antagonists inhibiting the BMP- and Wnt-pathway may serve to lock and stabilize the permanent chondrocyte phenotype and thus prevent their terminal differentiation. In contrast, osteophytic chondrocytes express genes with roles in the endochondral ossification process, which may account for their transient phenotype.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cartilage, Articular / metabolism*
  • Cartilage, Articular / pathology
  • Cell Differentiation / genetics
  • Chondrocytes / metabolism*
  • Chondrogenesis / genetics
  • Chondrogenesis / physiology
  • Gene Expression
  • Gene Expression Profiling / methods
  • Humans
  • Intercellular Signaling Peptides and Proteins / metabolism
  • Knee Joint / metabolism
  • Knee Joint / pathology
  • Middle Aged
  • Oligonucleotide Array Sequence Analysis / methods
  • Osteoarthritis, Knee / genetics
  • Osteoarthritis, Knee / metabolism
  • Osteoarthritis, Knee / pathology
  • Osteogenesis / genetics
  • Osteophyte / genetics*
  • Osteophyte / metabolism
  • Osteophyte / pathology
  • Phenotype
  • Reverse Transcriptase Polymerase Chain Reaction / methods

Substances

  • GREM1 protein, human
  • Intercellular Signaling Peptides and Proteins